Altered metabolism in pulmonary hypertension: fuelling the fire or just smoke?

Daisy Duan, Chenjuan Gu, Jonathan C. Jun

Source: Eur Respir J, 55 (4) 2000447; 10.1183/13993003.00447-2020
Journal Issue: April
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Daisy Duan, Chenjuan Gu, Jonathan C. Jun. Altered metabolism in pulmonary hypertension: fuelling the fire or just smoke?. Eur Respir J, 55 (4) 2000447; 10.1183/13993003.00447-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Inflammation in pulmonary arterial hypertension: is it time to quell the fire?
Source: Eur Respir J 2014; 43: 685-688
Year: 2014

Effects of cigarette smoke and hypoxia on pulmonary circulation in the guinea pig
Source: Eur Respir J 2011; 38: 617-627
Year: 2011

Inflammation in chronic thromboembolic pulmonary hypertension: accomplice or bystander in altered angiogenesis?
Source: Eur Respir J 2015; 46: 303-306
Year: 2015

Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension
Source: Eur Respir Rev, 30 (162) 210161; 10.1183/16000617.0161-2021
Year: 2021

Metabolic dysfunction associated with redox imbalance in pulmonary hypertension: Effects of the prolonged sildenafil use
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016

Tobacco smoke: A risk factor for pulmonary arterial hypertension? A case control study
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

Pulmonary hypertension in chronic obstructive pulmonary disease: the role of cigarette smoking
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006

Pulmonary hypertension and chronic lung disease: where are we headed?
Source: Eur Respir Rev, 28 (153) 190065; 10.1183/16000617.0065-2019
Year: 2019

Beyond personal smoking: does environmental tobacco smoke cause chronic obstructive pulmonary disease?
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005

How does inflammation contribute to pulmonary hypertension?
Source: Eur Respir J, 51 (1) 1702403; 10.1183/13993003.02403-2017
Year: 2018

Tobacco smoke in patients with pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Olfactory receptors in pulmonary arterial hypertension: A novel pathway of vascular remodeling?
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Iron deficiency in pulmonary arterial hypertension: A matter of definition!
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016

Reprogramming of cellular metabolism: driver for airway remodelling in COPD?
Source: Eur Respir J, 50 (5) 1702197; 10.1183/13993003.02197-2017
Year: 2017

Cadmium in tobacco smokers: a neglected link to lung disease?
Source: Eur Respir Rev, 27 (147) 170122; 10.1183/16000617.0122-2017
Year: 2018

Atrial fibrillation in the course of pulmonary embolism: just a little smoke or fuel to the fire?
Source: Virtual Congress 2020 – Cardiovascular morbidity and mortality after pulmonary embolism
Year: 2020

A crossroads between the heart and lungs: air pollution and pulmonary hypertension
Source: Eur Respir J, 53 (5) 1900654; 10.1183/13993003.00654-2019
Year: 2019

Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis?
Source: Eur Respir J 2010; 35: 730-734
Year: 2010

Pulmonary hypertension at exercise in COPD: does it matter?
Source: Eur Respir J 2013; 41: 1002-1004
Year: 2013

Sex differences in pulmonary hypertension: are we cleaning up the mess?
Source: Eur Respir J 2016; 47: 390-393
Year: 2016